Cargando…

Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell

OBJECTIVE: To investigate the oncogenic effect and clinical significance of RAC2 in pancarcinoma from the perspective of tumor immunity and cancer stem cell. METHODS: After in-depth mining of TCGA, GEO, UCSC, and other databases, basic information of the RAC2 gene and its expression in tumor tissues...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ranran, Li, Tianyu, Zhang, Guohong, Jia, Yejuan, Liu, Jingxuan, Pan, Lijia, Li, Yunfeng, Jia, Chunsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198763/ https://www.ncbi.nlm.nih.gov/pubmed/37214785 http://dx.doi.org/10.1155/2023/8485726

Ejemplares similares

Pan-Cancer Analysis of TLE3 Revealed Its Value in Tumor Microenvironment and Prognosis
por: Li, Tianyu, et al.
Publicado: (2022)

Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy
por: Cui, Jing, et al.
Publicado: (2022)

CCNF is a potential pancancer biomarker and immunotherapy target
por: Wei, Lifang, et al.
Publicado: (2023)

A comprehensive pancancer analysis reveals the potential value of RAR-related orphan receptor C (RORC) for cancer immunotherapy
por: He, Shengfu, et al.
Publicado: (2022)

Effect of Moxibustion on the Intestinal Flora of Rats with Knee Osteoarthritis Induced by Monosodium Iodoacetate
por: Chen, Yu, et al.
Publicado: (2020)

Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer
por: Song, Chengyang, et al.
Publicado: (2023)

Pancancer analysis of a potential gene mutation model in the prediction of immunotherapy outcomes
por: Yu, Lishan, et al.
Publicado: (2022)

Pancancer Analysis of the Prognostic and Immunotherapeutic Value of Progestin and AdipoQ Receptor 4
por: Yang, Ziyue, et al.
Publicado: (2022)

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
por: Xiong, Ye, et al.
Publicado: (2022)

Pancancer network analysis reveals key master regulators for cancer invasiveness
por: Jethalia, Mahesh, et al.
Publicado: (2023)

Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis
por: Li, Sicong, et al.
Publicado: (2022)

MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors
por: Lin, Xin, et al.
Publicado: (2022)

Pancancer survival analysis of cancer hallmark genes
por: Nagy, Ádám, et al.
Publicado: (2021)

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

A pancancer analysis of the oncogenic role of ZNRF2 in human tumours
por: Shi, Fujie, et al.
Publicado: (2023)

The Oncogenic Role and Immune Infiltration for CARM1 Identified by Pancancer Analysis
por: Liu, Kui, et al.
Publicado: (2021)

ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC
por: Zhou, Lingyi, et al.
Publicado: (2022)

Pancancer Analysis of the Oncogenic and Prognostic Role of NOL7: A Potential Target for Carcinogenesis and Survival
por: Liu, Qiaojun, et al.
Publicado: (2022)

Deep learning with multimodal representation for pancancer prognosis prediction
por: Cheerla, Anika, et al.
Publicado: (2019)

The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications
por: Yang, Liu, et al.
Publicado: (2021)

Diagnostic, Prognostic, and Immunological Roles of FABP4 in Pancancer: A Bioinformatics Analysis
por: Yang, Jing, et al.
Publicado: (2022)

Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma
por: Yu, Shian, et al.
Publicado: (2023)

SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis
por: Chen, Peng, et al.
Publicado: (2023)

Pancancer analysis of DNA methylation-driven genes using MethylMix
por: Gevaert, Olivier, et al.
Publicado: (2015)

The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis
por: Zhang, Shoudu, et al.
Publicado: (2023)

PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2
por: Bousquets-Muñoz, Pablo, et al.
Publicado: (2022)

The expression and significance of efferocytosis and immune checkpoint related molecules in pancancer samples and the correlation of their expression with anticancer drug sensitivity
por: Cheng, Lin, et al.
Publicado: (2022)

In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis
por: Wu, Zixuan, et al.
Publicado: (2022)

Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)
por: Wu, Changwu, et al.
Publicado: (2021)

Comprehensive Analysis of Glutamate-Rich WD Repeat-Containing Protein 1 and Its Potential Clinical Significance for Pancancer
por: Wu, Yumeng, et al.
Publicado: (2021)

Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistance
por: Chen, Weiwei, et al.
Publicado: (2023)

An Analysis of BMP1 Associated with m6A Modification and Immune Infiltration in Pancancer
por: Zhou, Yiyi, et al.
Publicado: (2022)

In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation
por: Krupar, Rosemarie, et al.
Publicado: (2020)

Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs
por: Osmanbeyoglu, Hatice U., et al.
Publicado: (2017)

Does the LHPP gene share a common biological function in pancancer progression?
por: Guo, Kai, et al.
Publicado: (2022)

Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology
por: Mall, Raghvendra, et al.
Publicado: (2022)

Multiomics dynamic learning enables personalized diagnosis and prognosis for pancancer and cancer subtypes
por: Lu, Yuxing, et al.
Publicado: (2023)

Learning Individual Survival Models from PanCancer Whole Transcriptome Data
por: Kumar, Neeraj, et al.
Publicado: (2023)

Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma
por: Deng, Chao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_466sqsc4hjgea605ds7c88dj50